INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF ANDROGEN RECEPTOR (AR), COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, Aug. 6 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/012678) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF ANDROGEN RECEPTOR (AR), COMPOSITIONS THEREOF, AND METHODS OF USE" on Jan 23, 2025. With publication no. WO/2025/160224, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ESAU, Christine (Arrowhead Pharmaceuticals, Inc.10102 Hoyt Park DriveSan Diego, California 92131), CARLSON, Jeffrey (Arrowhead Pharmaceuticals, Inc.502...